Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milnacipran for Fibromyalgia Syndrome (F02207 GE 304)
NCT00757731Phase 3Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Sep 2006
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of milnacipran in fibromyalgia syndrome (FMS), sponsored by Pierre Fabre Laboratories. Started Sep 2006; status: completed.
02
Drugs
milnacipran
03
Conditions
fibromyalgia syndrome (FMS)
Beyond the preview
Go deeper on NCT00757731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00757731.